Ten years of laparoscopic sleeve gastrectomy at the Military University Hospital in Prague
Authors:
J. Pažin 1; E. Koblihová 1,2; A. Turzová 1; Š. Schütz 1; M. Kasalický 1,2; Radek Pohnán 1,2
Authors place of work:
Chirurgická klinika 2. lékařské fakulty Univerzity Karlovy a Ústřední vojenská nemocnice – Vojenská fakultní, nemocnice Praha
1; 2. lékařská fakulta Univerzity Karlovy v Praze
2
Published in the journal:
Rozhl. Chir., 2021, roč. 100, č. 5, s. 232-238.
Category:
Původní práce
doi:
https://doi.org/10.33699/PIS.2021.100.5.234–240
Summary
Introduction: The aim of this study was to evaluate a group of bariatric patients operated at the Military University Hospital in Prague during the last 10 years (2011−2020), in whom laparoscopic sleeve gastrectomy was performed.
Methods: Retrospective survey of the internal operation database. The search used the following combination of keywords: “sleeve“, “LSG“ and the diagnosis “E6*“. A total of 279 operated patients were enrolled. We evaluated the sex, age at the time of surgery, complications, need for drainage, weight, BMI, presence of type two diabetes mellitus and any effect of the surgery on its improvement, length of hospital stay, follow-up duration and % excess weight loss.
Results: A total of 279 patients, including 195 women and 84 men, underwent laparoscopic sleeve gastrectomy in the period of 10 years. The mean age was 44.46 years. The average operating time was 111 minutes. The mean BMI of the patients before surgery was 42.24 and the weight was 123.4 kg. The mean BMI one year after the surgery corresponded to a decrease of approximately 10 and the mean weight of 93.8 kg. Rather severe acute postoperative complications occurred in 2.87% patients. An improvement or complete cure of type two diabetes mellitus was observed in 57.8% patients.
Conclusion: Currently, laparoscopic sleeve gastrectomy is the most common bariatric operation at the Military University Hospital in Prague. This study demonstrates a satisfactory effect of bariatric surgery in terms of long-term significant weight loss and an improvement or even cure of associated diseases such as type two diabetes mellitus, arterial hypertension and others.
Keywords:
bariatrics – laparoscopy – sleeve gastrectomy – obesity – Military University Hospital in Prague
Zdroje
1. Conway B, Rene A. Obesity as a disease: no lightweight matter. Obesity Reviews 2004;5(3):145–151. doi: 10.1111/j.1467- 789X.2004.00144.x.
2. Caballero B. Humans against obesity: Who will win? Adv Nutr. 2019 Jan; 10 (Suppl 1): S4–S9. doi: 10.1093/advances/ nmy055.
3. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery survey 2018: Similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021 Jan 12:1–12. doi: 10.1007/s11695-020-05207-7. Epub ahead of print.
4. Chung AY, Thompson R, Overby DW, et al. Sleeve gastrectomy: Surgical tips. Journal of Laparoendoscopic & Advanced Surgical Techniques 2018;28(8).930–937. doi: 10.1089/lap.2018.0392. Epub 2018 Jul 13.
5. Guzman-Pruneda FA, Brethauer SA. Gastroesophageal reflux after sleeve gastrectomy. 2021 Feb;25(2):542−550. doi: 10.1007/s11605-020-04786-1.
6. Sethi M, Patel K, Zagzag J, et al. Thirty-day readmission after laparoscopic sleeve gastrectomy—a predictable event? J Gastrointest Surg. 2016 Feb;20(2):244−252. doi: 10.1007/s11605-015-2978-x.
7. Rebibo L, Demouron M, Dembinski J, et al. Impact of routine 12 mm epigastric trocar site closure on incisional hernia after sleeve gastrectomy: A prospective before/after study. Obes Surg. 2019 Nov;29(11):3500−3507. doi: 10.1007/ s11695-019-03971-9.
8. Bakr AA, Fahmy MH, Elward AS, et al. Analysis of medium-term weight regain 5 years after laparoscopic sleeve gastrectomy. Obes Surg. 2019 Nov;29(11):3508−3513. doi: 10.1007/ s11695-019-04009-w.
9. Golzarand M, Toolabi K, Farid R. The bariatric surgery and weight losing: a meta- analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surg Endosc. 2017 Nov;31(11):4331−4345. doi: 10.1007/s00464-017-5505-1.
10. Kasalicky M, Dolezel R, Vernerova E, et al. Laparoscopic sleeve gastrectomy without over-sewing of the staple line is effective and safe. Wideochir Inne Tech Maloinwazyjne 2014 Mar;9(1):46−52. doi: 10.5114/wiitm.2014.40387.
11. Michalsky D, Dvorak P, Belacek J, et al. Radical resection of the pyloric antrum and its effect on gastric emptying after sleeve gastrectomy. Obes Surg. 2013 Apr;23(4):567−573. doi: 10.1007/s11695- 012-0850-6.
12. Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: The SLEEVEPASS randomized clinical trial. JAMA 2018 Jan 16;319(3):241−254. doi: 10.1001/ jama.2017.20313.
13. Samson R, Milligan G, Lewine E, et al. Effect of sleeve gastrectomy on hypertension. J Am Soc Hypertens. 2018 Nov;12(11):e19−e25. doi: 10.1016/j. jash.2018.09.007.
14. Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett‘ s esophagus after laparoscopic sleeve gastrectomy: Long-term follow-up. Obes Surg. 2017 Dec;27(12):3092−3101. doi: 10.1016/j.jash.2018.09.007.
15. Termine P, Boru CE, Turcu F, et al. The impact of the surgical technique on stenosis after laparoscopic sleeve gastrectomy: a single center study on 5235 patients. Minerva Surg. 021 Feb;76(1):43-49. doi: 10.23736/S0026-4733.20.08505-3.
16. Emile SH, Elfeki H, Elalfy K, et al. Laparoscopic sleeve gastrectomy then and now: An updated systematic review of the progress and short-term outcomes over the last 5 years. Surg Laparosc Endosc Percutan Tech. 2017 Oct;27(5):307−317. doi: 10.1097/SLE.0000000000000418.
17. Carandina S, Montana L, Danan M, et al. Laparoscopic sleeve gastrectomy learning curve: Clinical and economical impact. Obes Surg. 2019 Jan;29(1):143−148. doi: 10.1007/s11695-018-3486-3.
Štítky
Chirurgie všeobecná Ortopedie Urgentní medicínaČlánek vyšel v časopise
Rozhledy v chirurgii
2021 Číslo 5
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Cinitaprid – nové bezpečné prokinetikum s odlišným mechanismem účinku
- Cinitaprid v léčbě funkční dyspepsie – přehled a metaanalýza aktuálních dat
- Perorální antivirotika jako vysoce efektivní nástroj prevence hospitalizací kvůli COVID-19 − otázky a odpovědi pro praxi
Nejčtenější v tomto čísle
- Update podtlakové terapie pro rok 2021
- Posttraumatická interkostální plicní herniace – kazuistika
- Penetrující poranění břicha – vybrané kazuistiky
- 10 let laparoskopické tubulizace žaludku v Ústřední vojenské nemocnici Praha